S

Stenocare A/S
CSE:STENO

Watchlist Manager
Stenocare A/S
CSE:STENO
Watchlist
Price: 1.42 DKK 9.23% Market Closed
Market Cap: 61.6m DKK

Relative Value

The Relative Value of one STENO stock under the Base Case scenario is 0.39 DKK. Compared to the current market price of 1.42 DKK, Stenocare A/S is Overvalued by 72%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

STENO Relative Value
Base Case
0.39 DKK
Overvaluation 72%
Relative Value
Price
S
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
57
vs Industry
20
Median 3Y
30.9
Median 5Y
30.9
Industry
2.6
vs History
vs Industry
Median 3Y
-7.3
Median 5Y
-17.9
Industry
21.7
vs History
vs Industry
Median 3Y
-15.8
Median 5Y
-22.1
Industry
16.7
vs History
vs Industry
Median 3Y
-14
Median 5Y
-21.5
Industry
23.1
vs History
0
vs Industry
25
Median 3Y
8.7
Median 5Y
12.2
Industry
2.2
vs History
53
vs Industry
18
Median 3Y
29.9
Median 5Y
31.7
Industry
2.9
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
5.5
vs History
vs Industry
Median 3Y
-8.1
Median 5Y
-18.3
Industry
13.2
vs History
vs Industry
Median 3Y
-7.5
Median 5Y
-18.3
Industry
16.8
vs History
vs Industry
Median 3Y
-14.8
Median 5Y
-21.9
Industry
15.9
vs History
vs Industry
Median 3Y
-14.8
Median 5Y
-20.6
Industry
19.2
vs History
0
vs Industry
58
Median 3Y
6.4
Median 5Y
12.4
Industry
1.9

Multiples Across Competitors

STENO Competitors Multiples
Stenocare A/S Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DK
Stenocare A/S
CSE:STENO
61.6m DKK 10.9 -2.5 -3.2 -3.2
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.1 55 36.9 39.6
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
496.6B USD 5.4 19.8 16.2 21
CH
Roche Holding AG
SIX:ROG
259.2B CHF 4.2 27.5 11.7 13.7
UK
AstraZeneca PLC
LSE:AZN
212B GBP 4.9 30.2 108.4 158.6
CH
Novartis AG
SIX:NOVN
208.2B CHF 4.7 18.2 11.5 14.9
US
Merck & Co Inc
NYSE:MRK
251.4B USD 3.9 13.2 9.4 11.2
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.4 13.3 9.3 10.8
IE
Endo International PLC
LSE:0Y5F
209B USD 90.1 -71.5 331.1 830.4
US
Pfizer Inc
NYSE:PFE
143.2B USD 2.3 14.6 7.4 10.2
P/E Multiple
Earnings Growth PEG
DK
S
Stenocare A/S
CSE:STENO
Average P/E: 24
Negative Multiple: -2.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
55
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.8
29%
0.7
CH
Roche Holding AG
SIX:ROG
27.5
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
30.2
38%
0.8
CH
Novartis AG
SIX:NOVN
18.2
17%
1.1
US
Merck & Co Inc
NYSE:MRK
13.2
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
13.3
4%
3.3
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -71.5 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.6
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
DK
S
Stenocare A/S
CSE:STENO
Average EV/EBITDA: 438.8
Negative Multiple: -3.2
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
36.9
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.2
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.7
4%
2.9
UK
AstraZeneca PLC
LSE:AZN
108.4
10%
10.8
CH
Novartis AG
SIX:NOVN
11.5
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.4
6%
1.6
DK
Novo Nordisk A/S
CSE:NOVO B
9.3
2%
4.6
IE
E
Endo International PLC
LSE:0Y5F
331.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.4
1%
7.4
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
DK
S
Stenocare A/S
CSE:STENO
Average EV/EBIT: 1 881.3
Negative Multiple: -3.2
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.6
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.7
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
158.6
23%
6.9
CH
Novartis AG
SIX:NOVN
14.9
12%
1.2
US
Merck & Co Inc
NYSE:MRK
11.2
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
10.8
1%
10.8
IE
E
Endo International PLC
LSE:0Y5F
830.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
8%
1.3